Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zeo ScientifiX's gross profit for the
three
months ended in Apr. 2026 was $2.06 Mil. Zeo ScientifiX's gross profit for the trailing twelve months (TTM) ended in Apr. 2026 was $5.70 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Zeo ScientifiX's gross profit for the
three
months ended in Apr. 2026 was $2.06 Mil. Zeo ScientifiX's Revenue for the
three
months ended in Apr. 2026 was $2.58 Mil. Therefore, Zeo ScientifiX's Gross Margin % for the quarter that ended in Apr. 2026 was 79.62%.
Zeo ScientifiX had a gross margin of 79.62% for the quarter that ended in Apr. 2026 => Durable competitive advantage
During the past 13 years, the highestGross Margin % of Zeo ScientifiX was 90.23%. The lowest was 48.65%. And the median was 82.20%.
Warning Sign:
Zeo ScientifiX Inc gross margin has been in long-term decline. The average rate of decline per year is -1.6%.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Zeo ScientifiX had a gross margin of 79.62% for the quarter that ended in Apr. 2026 => Durable competitive advantage
Zeo ScientifiX Gross Profit Related Terms
Zeo ScientifiX Gross Profit Historical Data
* Premium members only.
The historical data trend for Zeo ScientifiX's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Zeo ScientifiX's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zeo ScientifiX Gross Profit vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's Gross Profit distribution charts can be found below:
* The bar in red indicates where Zeo ScientifiX's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.70 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Zeo ScientifiX (ZEOX) has a Gross Profit of $5.70 Mil as of Apr. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Zeo ScientifiX and its competitors.
Is Zeo ScientifiX's Gross Profit too high?
Zeo ScientifiX's current Gross Profit is $5.70 Mil. Overall, Zeo ScientifiX has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zeo ScientifiX's Gross Profit compare to FBLG and INAB?
Zeo ScientifiX's Gross Profit of $5.70 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Biotechnology company?
A good Gross Profit depends on the Biotechnology industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Zeo ScientifiX and its competitors. Zeo ScientifiX's current Gross Profit is $5.70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeo ScientifiX stock overvalued right now?
Based on GuruFocus' analysis, Zeo ScientifiX (ZEOX) is currently considered Possible Value Trap. The stock's GF Value™ is $2.61, compared to a current price of $1.36 — trading 47.9% below its estimated fair value. The current Gross Profit is $5.70 Mil. Zeo ScientifiX's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Zeo ScientifiX (ZEOX), the current Gross Profit is $5.70 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zeo ScientifiX (ZEOX) Overvalued in 2026?
Based on GuruFocus' analysis, Zeo ScientifiX stock appears to be undervalued.
The current stock price of $1.36 is trading 47.9% below its estimated GF Value™ of $2.61.
GuruFocus considers Zeo ScientifiX to be Possible Value Trap.
Key valuation signals for ZEOX:
Gross Profit: $5.70 Mil
GF Value™: $2.61 vs. price of $1.36 (47.9% below fair value)
No single metric tells the full story. See the ZEOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
46GF Score
Get the complete analysis for ZEOX
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZEOX has been successfully added to your 
